A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

Exclusion Criteria

• •The subjects with existing or previous conditions that may influence the pharmacokinetics of drugs
• •The subjects hypersensitive to any of the Investigational Product components or other drug components
• •The subjects with clinically significant active chronic conditions
• •The subjects with a positive urine drug test result or a history of drug abuse or dependence.
• •The subjects who are pregnant or lactating